Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Coppo

Showing results (81-90 of 199) with videos related to

Pageof 20
Sort By:
Kidney International Reports|February 14, 2022
Proteinuria Increases the PLASMIC and French Scores Performance to Predict Thrombotic Thrombocytopenic Purpura in Patients With Thrombotic Microangiopathy SyndromeNicolas Fage, Corentin Orvain, Nicolas Henry, et al.
Leukemia & Lymphoma|April 1, 2021
Role of D(T)PACE-based regimens as treatment of multiple myeloma with extramedullary relapse or refractory diseaseTony Huynh, Elise Corre, Marie-Paule Lemonnier, et al.
Transfusion|February 24, 2015
Platelet transfusion and catheter insertion for plasma exchange in patients with thrombotic thrombocytopenic purpura and a low platelet countEtienne Riviere, Mélanie Saint-Léger, Chloé James, et al.
Blood Advances|December 1, 2023
Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experienceNicolas Béranger, Paul Coppo, Vassilis Tsatsaris, et al.
Clinical Case Reports|April 10, 2025
A Thrombocytopenic Thrombotic Purpura in a Patient With a Metastatic HER2+ Breast Cancer: Description of a Case ReportRaffaele Longo, Benjamin Savenkoff, Romane Ribal, et al.
Journal of the American Society of Nephrology : JASN|February 24, 2004
Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 casesMarie-Agnès Dragon-Durey, Véronique Frémeaux-Bacchi, Chantal Loirat, et al.
BMC Pregnancy and Childbirth|June 18, 2015
Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable diseaseYahsou Delmas, Sébastien Helou, Pierre Chabanier, et al.
Blood Advances|January 15, 2025
N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTPTim Postmus, Nelly Schilder, Juliana Ferreira de Santana, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 20, 2019
Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpuraOlivier Garraud, Sandrine Malot, Raoul Herbrecht, et al.
British Journal of Haematology|July 19, 2006
BCR-ABL activates STAT3 via JAK and MEK pathways in human cellsPaul Coppo, Stéphane Flamant, Véronique De Mas, et al.
Pageof 20

Showing results (81-90 of 199) with videos related to

Sort By:
Pageof 20
Kidney International Reports|February 14, 2022
Proteinuria Increases the PLASMIC and French Scores Performance to Predict Thrombotic Thrombocytopenic Purpura in Patients With Thrombotic Microangiopathy SyndromeNicolas Fage, Corentin Orvain, Nicolas Henry, et al.
Leukemia & Lymphoma|April 1, 2021
Role of D(T)PACE-based regimens as treatment of multiple myeloma with extramedullary relapse or refractory diseaseTony Huynh, Elise Corre, Marie-Paule Lemonnier, et al.
Transfusion|February 24, 2015
Platelet transfusion and catheter insertion for plasma exchange in patients with thrombotic thrombocytopenic purpura and a low platelet countEtienne Riviere, Mélanie Saint-Léger, Chloé James, et al.
Blood Advances|December 1, 2023
Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experienceNicolas Béranger, Paul Coppo, Vassilis Tsatsaris, et al.
Clinical Case Reports|April 10, 2025
A Thrombocytopenic Thrombotic Purpura in a Patient With a Metastatic HER2+ Breast Cancer: Description of a Case ReportRaffaele Longo, Benjamin Savenkoff, Romane Ribal, et al.
Journal of the American Society of Nephrology : JASN|February 24, 2004
Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 casesMarie-Agnès Dragon-Durey, Véronique Frémeaux-Bacchi, Chantal Loirat, et al.
BMC Pregnancy and Childbirth|June 18, 2015
Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable diseaseYahsou Delmas, Sébastien Helou, Pierre Chabanier, et al.
Blood Advances|January 15, 2025
N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTPTim Postmus, Nelly Schilder, Juliana Ferreira de Santana, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 20, 2019
Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpuraOlivier Garraud, Sandrine Malot, Raoul Herbrecht, et al.
British Journal of Haematology|July 19, 2006
BCR-ABL activates STAT3 via JAK and MEK pathways in human cellsPaul Coppo, Stéphane Flamant, Véronique De Mas, et al.
Pageof 20